Filing Details
- Accession Number:
- 0001104659-15-021407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-20 16:20:07
- Reporting Period:
- 2015-03-18
- Filing Date:
- 2015-03-20
- Accepted Time:
- 2015-03-20 16:20:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1264587 | Stemline Therapeutics Inc | STML | Pharmaceutical Preparations (2834) | 450522567 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Stemline Therapeutics, Inc. 750 Lexington Avenue, Eleventh Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-18 | 5,421 | $4.09 | 8,673 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-18 | 1,388 | $16.12 | 7,285 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2015-03-18 | 5,421 | $0.00 | 5,421 | $4.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-04-01 | No | 4 | M | Direct |
Footnotes
- In connection with the exercise of expiring stock options, 1,388 shares were sold to satisfy the exercise price.
- Reflects the weighted average sale price. The range of prices for such transaction is $16.12 to $16.13. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- The options vested in full on April 10, 2010.
Billionaire Hedge Funds
